A CONSENSUS Development Conference was held at the National Institutes of Health (NIH) on March 1, 2, and 3, 1982, to seek a position on issues involving total hip-joint replacement (THR).
At the NIH, Consensus Development Conferences bring together investigators in the biomedical sciences, practicing physicians, consumers, and advocate groups to provide a scientific assessment of technologies, including drugs, devices, and procedures, and to seek agreement on their safety and effectiveness.
On the first two days of the meeting, a consensus development panel and members of the audience heard evidence presented on the following key questions:
• What are the indications and contraindications for THR?
• What are the current scientific principles guiding selection of materials, devices, and procedures for THR?
• What are the short-term and long-term prognoses for medical status and functional activity after THR?
• What are the medical and surgical complications of THR?
• What are
Total Hip-Joint Replacement in the United States. JAMA. 1982;248(15):1817–1821. doi:10.1001/jama.1982.03330150017003
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: